TickerFacts.

Acrivon Therapeutics, Inc. (ACRV): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

38.51M
Year ended 2025-12-31
2021-12-31: 1.74M2022-12-31: 4.12M2023-12-31: 22.08M2024-12-31: 33.79M2025-12-31: 38.51M38.51M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3138.51M+14.0%2026-03-19, From 2025-01-01
2024-12-3133.79Mn/c2026-03-19, From 2024-01-01
2023-12-3122.08M+435.6%2025-03-27, From 2023-01-01
2022-12-314.12M+136.4%2024-03-28, From 2022-01-01
2021-12-311.74Mn/a2023-03-28, From 2021-01-01